These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37254940)
21. COVID-19 vaccine acceptance and hesitancy in Ghana: A systematic review. Akrong GB; Hiadzi RA; Donkor AB; Anafo DK PLoS One; 2024; 19(6):e0305993. PubMed ID: 38917063 [TBL] [Abstract][Full Text] [Related]
22. Healthcare provider Communication and Data-Informed Message Strategies for Encouraging Older Adults to Stay up to Date on COVID-19 Vaccination. Totzkay D; Fraustino JD; Costello LM; Kunkle CE J Appl Gerontol; 2024 Sep; 43(9):1228-1240. PubMed ID: 38546107 [TBL] [Abstract][Full Text] [Related]
23. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China. Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682 [TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis. Dey S; Kusuma YS; Kant S; Kumar D; Gopalan RB; Sridevi P; Aggarwal S Pathog Glob Health; 2024 Mar; 118(2):182-195. PubMed ID: 38014567 [TBL] [Abstract][Full Text] [Related]
25. Message testing in India for COVID-19 vaccine uptake: What appeal and what messenger are most persuasive? Limaye RJ; Erchick DJ; Balgobin K; Michel A; Schulz G Hum Vaccin Immunother; 2022 Nov; 18(6):2091864. PubMed ID: 35829738 [TBL] [Abstract][Full Text] [Related]
26. Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021. Bokemper SE; Gerber AS; Omer SB; Huber GA Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845032 [TBL] [Abstract][Full Text] [Related]
27. Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence. Chou WS; Budenz A Health Commun; 2020 Dec; 35(14):1718-1722. PubMed ID: 33124475 [TBL] [Abstract][Full Text] [Related]
28. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Peters MDJ Int J Nurs Stud; 2022 Jul; 131():104241. PubMed ID: 35489108 [TBL] [Abstract][Full Text] [Related]
29. Futile or fertile? The effect of persuasive strategies on citizen engagement in COVID-19 vaccine-related tweets across six national health departments. Wang D; Lu J; Zhong Y Soc Sci Med; 2023 Jan; 317():115591. PubMed ID: 36493501 [TBL] [Abstract][Full Text] [Related]
30. COVID-19 Vaccine Hesitancy: Shortening the Last Mile. Chevallier C; Hacquin AS; Mercier H Trends Cogn Sci; 2021 May; 25(5):331-333. PubMed ID: 33618982 [TBL] [Abstract][Full Text] [Related]
32. Perceptions and Concerns Regarding COVID-19 Vaccination in a Military Base Population. Theis SR; Li PC; Kelly D; Ocampo T; Berglund A; Morgan D; Markert R; Fisher E; Burtson K Mil Med; 2022 Oct; 187(11-12):e1255-e1260. PubMed ID: 34117501 [TBL] [Abstract][Full Text] [Related]
33. Exploring Hesitancy, Motivations, and Practical Issues for COVID-19 Vaccination Among Vaccine-Hesitant Adopter Parents Using the Increasing Vaccination Model. Purvis RS; Moore R; Willis DE; Li J; Selig JP; Kraleti S; Imran T; McElfish PA J Pediatr Health Care; 2024; 38(4):456-467. PubMed ID: 38430095 [TBL] [Abstract][Full Text] [Related]
34. Stressing the personal benefits of the covid-19 vaccine might encourage more people to accept it. Saul H; Gursul D BMJ; 2021 Dec; 375():n2923. PubMed ID: 34893477 [TBL] [Abstract][Full Text] [Related]
35. Impact of COVID-19 on vaccine confidence and uptake: A systematic literature review. Vojtek I; van Wouw M; Thomson A Hum Vaccin Immunother; 2024 Dec; 20(1):2384180. PubMed ID: 39106971 [TBL] [Abstract][Full Text] [Related]
36. Presidents and vaccines: head of state inoculation as a tool for vaccine promotion. Collart L; Lunanga E; Stoop N; Verpoorten M Front Public Health; 2024; 12():1364927. PubMed ID: 38808000 [TBL] [Abstract][Full Text] [Related]
37. The role of mental well-being in the effects of persuasive health messages: A scoping review. Dolinšek Š; Scholz C; Giani S; van Weert JCM; van den Putte B; Meppelink CS Soc Sci Med; 2024 Jul; 353():117060. PubMed ID: 38941728 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective. Gerussi V; Peghin M; Palese A; De Martino M; Graziano E; Chiappinotto S; Fonda F; Bontempo G; Semenzin T; Martini L; Isola M; Tascini C Hum Vaccin Immunother; 2024 Dec; 20(1):2358565. PubMed ID: 38825984 [TBL] [Abstract][Full Text] [Related]
39. Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana. Tlale LB; Gabaitiri L; Totolo LK; Smith G; Puswane-Katse O; Ramonna E; Mothowaeng B; Tlhakanelo J; Masupe T; Rankgoane-Pono G; Irige J; Mafa F; Kolane S PLoS One; 2022; 17(2):e0263375. PubMed ID: 35120163 [TBL] [Abstract][Full Text] [Related]
40. COVID-19 Vaccination Attitudes and Intention: Message Framing and the Moderating Role of Perceived Vaccine Benefits. Borah P; Hwang J; Hsu YCL J Health Commun; 2021 Aug; 26(8):523-533. PubMed ID: 34424140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]